Skip to Content

MetLife Inc - Stock Quote MET

Rating as of

Morningstar's MetLife Inc Stock Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

MetLife Performing Well So Far, but Variable Investment Income Likely Still Elevated

Rajiv Bhatia, CFA Equity Analyst

Analyst Note

| Rajiv Bhatia, CFA |

No-moat MetLife is off to a good start in 2022. Adjusted earnings per share in the first quarter came in at $2.08, well ahead of the FactSet consensus estimate of $1.65. Variable investment income continues to be elevated, though it was down year over year. Variable investment income is primarily private equity returns and is reported on a lag. As a result, we expect this to decline more meaningfully in the coming quarters as public and private company valuations have turned south. Overall, there was little in the press release that would alter our long-term view of MetLife, and we will maintain our fair value estimate of $56 per share.

Read Full Analysis

MetLife Inc's Company Profile

Business Description

MetLife--once a mutual company before the 2000 demutualization--is the largest life insurer in the U.S. by assets and provides a variety of insurance and financial services products. Outside the United States, MetLife operates in Japan and more than 40 countries in Latin America, Asia-Pacific, Europe, and the Middle East.

Contact
200 Park Avenue
New York, NY, 10166-0188
T +1 212 578-9500
Sector Financial Services
Industry Insurance - Life
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type Slow Growth
Employees 43,000

MetLife Inc's Related Articles & News